Mostrando 4 resultados de: 4
Área temáticas
Microorganismos, hongos y algas(4)
Enfermedades(2)
Farmacología y terapéutica(2)
Medicina y salud(1)
Origen
scopus(4)
Breadth and function of antibody response to acute SARS-CoV-2 infection in humans
ArticleAbstract: Serological and plasmablast responses and plasmablast-derived IgG monoclonal antibodies (MAbs) havePalabras claves:Autores:Chen C.P., Chen T.H., Cheng C.Y., Cheng S.H., Daniels R.S., Harding A.C., Harvey R., Huang C.G., Huang K.Y.A., Huang Y.C., Hussain S., James W.S., Jan J.T., Javier Gilbert Jaramillo, Knight M.L., Lin T.Y., Lin Y.C., Liu X., Ma C., McCauley J.W., Rijal P., Schimanski L., Shih S.R., Tan T.K., Townsend A.R.Fuentes:scopusErratum: Breadth and function of antibody response to acute SARS-CoV-2 infection in humans (PLoS Pathog (2021) 17:2 (e1009352) DOI: 10.1371/journal.ppat.1009352)
OtherAbstract: There is an error in the caption for S2 Fig.The cells in this experiment were transduced to expressPalabras claves:Autores:Chen C.P., Chen T.H., Cheng C.Y., Cheng S.H., Daniels R.S., Harding A.C., Harvey R., Huang C.G., Huang K.Y.A., Huang Y.C., Hussain S., James W.S., Jan J.T., Javier Gilbert Jaramillo, Knight M.L., Lin T.Y., Lin Y.C., Liu X., Ma C., McCauley J.W., Rijal P., Schimanski L., Shih S.R., Tan T.K., Townsend A.R.Fuentes:scopusTwo doses of SARS-CoV-2 vaccination induce robust immune responses to emerging SARS-CoV-2 variants of concern
ArticleAbstract: The extent to which immune responses to natural infection with severe acute respiratory syndrome corPalabras claves:Autores:Abuelgasim H., Adele S., Adland E., Adlou S., Alhussni A., Ali M., Amini A., Barnes E., Blackwell L., Bridges-Webb A., Brown A., Brown H., Camara S., Carroll M.W., Cassar M.P., Chinnakannan S., Conlon C.P., Csala A., Cutteridge J., de Lara C., de Oliveira T., de Silva T.I., Deeks A.S., Denly L., Dimitriadis S., Dold C., Dong T., Donnison T., Dunachie S.J., Duncan C.J.A., Edmans M., Frater J., Fries A., Goulder P., Hackstein C.P., Harding A.C., Hill J., Ho L.P., Holmes J., Huang K.Y.A., Hutchings C.L., James W.S., Javier Gilbert Jaramillo, Jay C., Jeffery K., Johnson S.A., Kasanyinga M., Kerneis S., Klenerman P., Knight J.C., Knight M.L., Lee L.N., Li W., Lillie K., Linder A., Longet S., Malone T., Marinou S., Marjot T., Matthews P.C., Mehta H., Mentzer A.J., Moore S.C., Neubauer S., Ogbe A., O’Donnell D., Pace M., Payne R.P., Peng Y., Petousi N., Phalora P., Phillips E., Pollard A.J., Raman B., Richter A., Rijal P., Robinson N., Rongkard P., Schimanski L., Sigal A., Silva-Reyes L., Simmons B., Skelly D.T., Stafford L., Talbot N.P., Tan T.K., Thomas S.R., Tipoe T., Tipton T., Townsend A.R., Turtle L., Watson A.J.R., Weeks E., Wilson R., Zacharopoulou P.Fuentes:scopusStructures and therapeutic potential of anti-RBD human monoclonal antibodies against SARS-CoV-2
ArticleAbstract: Background: Administration of potent anti-receptor-binding domain (RBD) monoclonal antibodies has bePalabras claves:Antibody cocktail, Antibody-antigen complex, Human monoclonal antibody, In vitro and in vivo function, Receptor-binding domain epitope, SARS-COV-2Autores:Buttigieg K.R., Carroll M.W., Charlton S., Chen C., Chen C.P., Chen X., Cheng S.H., Donat R.F., Duyvesteyn H.M.E., Fry E.E., Ginn H.M., Harding A.C., Huang K.Y.A., James W.S., Javier Gilbert Jaramillo, Lien C.E., Lin M.Y., Lin T.Y., Ma C., Qin L., Ren J., Rijal P., Schimanski L., Stuart D.I., Tan T.K., Townsend A.R., Tree J.A., Zhao Y., Zhou D.Fuentes:scopus